XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating expenses:        
Research and development, net $ (1,876) $ (2,390) $ (4,217) $ (4,460)
Marketing and sales (233) (499) (666) (1,097)
General and administrative (634) (865) (1,294) (1,773)
Operating loss (2,743) (3,754) (6,177) (7,330)
Equity in net gain (loss) of an affiliated company (598) 106 (1,344) 16
Financing income (expenses), net 10 (175) 141 176
Net loss $ (3,331) $ (3,823) $ (7,380) $ (7,138)
Basic and diluted net loss per share from continuing operations $ (0.02) $ (0.03) $ (0.04) $ (0.05)
Weighted average number of shares outstanding used in computing basic and diluted net (loss) profit per share 199,973,047 153,480,701 177,349,786 144,363,756